Tyra Biosciences secured $200M private placement financing from institutional investors for R&D and operations.

Tyra Biosciences' stock rose significantly after the company announced a $200 million private placement financing agreement with institutional and accredited investors. The biotechnology firm plans to use the proceeds for research and development activities and other operational purposes. Notable investors in the financing round include RA Capital Management, Boxer Capital, BVF Partners, Nextech Invest Ltd, OrbiMed, and 5AM Ventures.

February 02, 2024
4 Articles

Further Reading